PCWorld explains how to identify unauthorized access to your Google account by checking logged-in devices and linked third-party apps. Regular security audits are essential since hackers can exploit ...

An internal Immigration and Customs Enforcement document in May shows that ICE told officers and agents they can forcibly enter homes of people subject to deportation without warrants signed by judges ...

House Financial Services Chairman French Hill is on a campaign to embed financial regulations into law, a move to make it much more difficult for a different administration to reverse course. Hill, ...

Think about someone you’d call a friend. What’s it like when you’re with them? Do you feel connected? Like the two of you are in sync? In today’s story, we’ll meet two friends who have always been in ...

Google on Thursday introduced a new AI experiment for the web browser: the Gemini-powered product Disco, which helps to turn your open tabs into custom applications. With Disco, you can create what ...

While there is no question that AI will have a significant impact on the future of work, precisely what AI will look like in four years is yet to be determined. Many futurists suggest what’s to come, ...

Hospitals and health systems are formalizing leadership roles focused on clinical excellence and professionalism — particularly at academic medical centers. Leaders say their institutions see the ...

Artificial Intelligence represents a fundamental change in how businesses operate and interact with consumers. One of the most significant advancements in AI is embedding technology, a key ...

Oct 29 (Reuters) - U.S. President Donald Trump has told U.S. troops he was prepared to send "more than the National Guard" into U.S. cities if needed, in the latest demonstration of his willingness to ...

Mary Cunningham is a reporter for CBS MoneyWatch. She previously worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program. ChatGPT users will soon have a new way ...

Replimune received FDA acceptance for its RP1 BLA resubmission in advanced melanoma, with a PDUFA date set for April 2026. REPL stock surged nearly 100% on the news, but FDA acceptance only restarts ...